-+ 0.00%
-+ 0.00%
-+ 0.00%

Hyloris Strikes Exclusive Distribution Deal for Phosphate Supplement

MT Newswires·11/09/2026 00:33:03
Listen to the news
12:33 AM EST, 11/09/2026 (MT Newswires) -- Hyloris Pharmaceuticals (HYL.BR) agreed to make AFT Pharmaceuticals an exclusive distributor of its proprietary phosphate oral liquid formulation across Australia, Canada, New Zealand, Hong Kong and Singapore. Both parties will split profits from commercial sales of the phosphate supplement, the Belgian biopharmaceutical company said Nov. 6. The company's phosphate oral liquid product is intended for people with hypophosphatemia, or a low level of phosphate in the blood.